Results 21 to 30 of about 277 (133)
Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
Frontiers in Oncology, 2022 Uveal melanoma is the most common primary intraocular malignancy. The aim of this retrospective study was to report the results after ruthenium-106 (Ru-106) plaque brachytherapy for uveal melanoma in terms of tumor control, visual acuity, radiation ...
Gilda Cennamo +12 more
doaj +1 more source
Reduced blood flow by laser speckle flowgraphy after 125I-plaque brachytherapy for uveal melanoma
BMC Ophthalmology, 2022 Background To determine whether reductions in retinal and choroidal blood flow measured by laser speckle flowgraphy are detected after 125I-plaque brachytherapy for uveal melanoma. Methods In a cross-sectional study, retinal and choroidal blood flow were
Michelle R. Tamplin +10 more
doaj +1 more source
Complications and adverse events of plaque brachytherapy for ocular melanoma
Journal of Contemporary Brachytherapy, 2019 Plaque brachytherapy is a well-accepted modality to manage selected cases of ocular melanoma. Although this modality provides validated oncologic and quality of life benefits, severe complications and adverse events can occur.
Krishi Peddada +3 more
doaj +1 more source
Treatment planning considerations for 125I eye plaque brachytherapy
Journal of Contemporary Brachytherapy, 2019 Effective cancer brachytherapy requires a treatment plan that delivers high-dose to tumor, while minimizing the dose to critical normal tissues. Therefore, an accurate knowledge of the sources and magnitude of the techniques is essential for producing robust and well optimized-plans. The purpose of this technical note is to establish general procedures
David Miguel +6 more
openaire +3 more sources
Subretinal lipid exudation associated with untreated choroidal melanoma
Indian Journal of Ophthalmology, 2011 Subretinal lipid exudation in an untreated choroidal melanoma is very rare. It is seen following plaque radiotherapy in choroidal melanoma. There is only one case report of untreated choroidal melanoma with massive lipid exudation in a patient with ...
C K Minija, Mahesh P Shanmugam
doaj +1 more source
HeliyonPurpose: To examine incidence, risk factors, and outcomes of cataract surgery after plaque brachytherapy for posterior uveal melanoma. Design: Retrospective interventional cohort study contrasted with general population data.
Viktor T. Gill, Gustav Stålhammar
doaj +1 more source
Changes in meibum composition following plaque bachytherapy for choroidal melanoma
BMJ Open Ophthalmology, 2020 Objectives Dry eye is common when external beam radiation is used for the treatment of choroidal melanoma (CM). As meibum structure and composition have been related to dry eye, we determined if plaque bachytherapy for CM alters meibum composition.Design
Aparna Ramasubramanian +2 more
doaj +1 more source
“Triple support pocket” for placing brachytherapy plaques for anterior segment tumors
Indian Journal of OphthalmologyBackground: Anterior segment tumors are rare tumors with limited management options. In small-sized lesions, plaque brachytherapy is advisable. The placement techniques of plaques for anterior segment tumors are completely different from the techniques ...
Neiwete Lomi +5 more
doaj +1 more source
Case Reports in Ophthalmology, 2012 Purpose: To report the effective treatment of radiation macular edema following ruthenium-106 plaque brachytherapy for a choroidal melanoma with a dexamethasone 0.7-mg (Ozurdex®) intravitreal implant.
Andrea Russo +12 more
doaj +1 more source
Intraocular Metastasis: Differential Diagnosis and Management
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Intraocular metastases represent the most common type of malignant intraocular tumour in adults. These commonly affect the choroid but can also involve the iris, ciliary body, retina, vitreous, optic disc or lens. Breast and lung cancer are the most common origins of intraocular metastases.
Genovefa Μachairoudia +3 more
wiley +1 more source